PharmID
Seattle, US · Founded 2017 · Delaware corporation
Founders & leadership
BM
Brian MarquardtNamed on SEC filing
SV
Scott Van VurenNamed on SEC filing
TG
Tim GibbonsNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$6M disclosed across 2 rounds · 2017–2018
▶$5MraisedFeb 2020 · 13 investors · Other Health CareRule 506(b)
▶$5MraisedFeb 2020 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brian MarquardtExecutive Officer, Director
- Christopher SwasandDirector
- Tom PiersonExecutive Officer
- J. Scott Van VurenExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$1MraisedOct 2017 · 11 investors · PharmaceuticalsRule 506(b)
▶$1MraisedOct 2017 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Brian MarquardtDirector
- Scott Van VurenDirector
- Tim GibbonsExecutive Officer, Director
- Offering amount
- $1.1M
- Amount sold
- $1M
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has PharmID raised?
- PharmID has disclosed $6M raised across 2 rounds.
- Where is PharmID headquartered?
- PharmID is headquartered in Seattle, US.